Dra. María Eugenia Jiménez Corona is a Surgeon at the Faculty of Medicine of the National Autonomous University of Mexico (UNAM). She has a Master's and PhD in Epidemiology (UNAM), a Diplomate in Vaccinology at the Pasteur Institute, Paris France, and a Latin American Diploma in Vaccinology (UNAM). Dra. Corona belongs to the National System of Researchers (Level 2) since 2004.
She has served as Head of Department in the General Directorate of Epidemiology, and in the National Institute of Medical Sciences and Nutrition Salvador Zubirán, Researcher in Medical Sciences at the National Institute of Public Health, Director of Research at CONAMED and Head of the Research Area at BIRMEX.
She has articles published in national and international journals, has presented more than 90 papers in national and international academic forums, has 7 chapters of books published and 3 in press, on topics of Epidemiology and Research Methodology. She has obtained funding as principal investigator and co-investigator (ICYTDF, CONACyT, WHO).
She has been a tutor of undergraduate and graduate students, with 12 students graduated of specialty and masters. She has been an undergraduate professor at the Faculty of Medicine, UNAM, and is currently professor and tutor of the Masters and Doctoral Program in Medical and Dental Health Sciences at UNAM. Dra. Corona has participated in the coordination of the Master's Degree in Health Sciences with concentration area in Vaccology in collaboration with BIRMEX-INSP. She has obtained several research awards, highlighting the Chiron Vaccines Award for Epidemiology of Infectious Diseases (2004), awarded by the International Society of Infectious Diseases.
Since July 2013, Dra. María Eugenia Jiménez Corona serves as Deputy General Director of Epidemiology, Secretary of Health.
Areas of Expertise (10)
Organization & Management
Institut Pasteur, Paris: Diplomate, Vaccination, Vaccinology 2008
National Autonomous University of Mexico (UNAM): D.Sc., Epidemiology 2007
National Autonomous University of Mexico (UNAM): M. in C., Epidemiology 2000
National Autonomous University of Mexico (UNAM): Medical Surgeon, Medicine 1989
- National System of Researchers - Member
- CONAMED - Director of Research
- BIRMEX - Head of the Research Area
Featured Articles (3)
Factors Associated With Tuberculin Reactivity in Two General Hospitals in MexicoInfection Control & Hospital Epidemiology
María Eugenia Jiménez-Corona, et al.
2015 To identify risk factors associated with tuberculin reactivity in healthcare workers (HCWs). Cross-sectional survey of tuberculin reactivity (2 TU of purified protein derivative (PPD) RT23, using the Mantoux two-step test). Two general hospitals located in a region with a high prevalence of tuberculosis and high bacille Calmette-Guérin (BCG) coverage...
Association of diabetes and tuberculosis: impact on treatment and post-treatment outcomesThorax
María Eugenia Jiménez-Corona, Luis Pablo Cruz-Hervert, Lourdes García-García, Leticia Ferreyra-Reyes, Guadalupe Delgado-Sánchez, Miriam Bobadilla-del-Valle, Sergio Canizales-Quintero, Elizabeth Ferreira-Guerrero, Renata Báez-Saldaña, Norma Téllez-Vázquez, Rogelio Montero-Campos, Norma Mongua-Rodriguez, Rosa Areli Martínez-Gamboa, José Sifuentes-Osornio, Alfredo Ponce-de-León
2013 To determine the clinical consequences of pulmonary tuberculosis (TB) among patients with diabetes mellitus (DM). We conducted a prospective study of patients with TB in Southern Mexico. From 1995 to 2010, patients with acid-fast bacilli or Mycobacterium tuberculosis in sputum samples underwent epidemiological, clinical and microbiological evaluation. Annual follow-ups were performed to ascertain treatment outcome, recurrence, relapse and reinfection.
Clinical Consequences and Transmissibility of Drug-Resistant Tuberculosis in Southern MexicoJAMA Internal Medicine
Maria de Lourdes García-García, MD, DrSc; Alfredo Ponce-de-León, MD; Maria Eugenia Jiménez-Corona, MD; et al
2000 Background Consequences of drug-resistant tuberculosis (TB) in developing countries using directly observed treatment, short-course (DOTS), are not well defined. Objective To determine the impact of drug resistance on clinical outcome and transmission of TB under programmatic conditions.